![](https://etimg.etb2bimg.com/thumb/msid-112173203,imgsize-27682,width-1200,height=765,overlay-ethealth/pharma/financial-performance/teva-pharma-raises-2024-targets-on-strength-in-generic-branded-drugs.jpg)
Teva Pharma raises 2024 targets on strength in generic, branded drugs
London: Teva Pharmaceutical Industries raised its annual forecasts on Wednesday, as it benefits from strong demand for its cheaper copycat medicines and branded treatment for Huntington's disease. The company is banking on its branded medicine trio - …